Modi S, Jacot W, Yamashita T, Sohn J, et al. Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer. N Engl J Med 2022 Jun 5. doi: 10.1056/NEJMoa2203690.
PMID: 35665782